You are here
Oct 2013 Let's say that you are a medical consumer who lives in the United States. We are all medical consumers at some point in our lives. Financially, does it make more sense for you to save your own stem cells for later use, or to assume that you will buy an off-the-shelf stem cell therapy when the time comes that you need one?
Oct 2013 The Genetics Policy Institute (GPI) is a leading promoter and defender of stem cell research and other cutting-edge medical research targeting cures. We are the catalyst and provide leadership to the Pro-Cures Movement, an influential global network of stakeholders - from patient-advocacy to science and industry.
Oct 2013 Ivan N. Rich, PhD, Founder & CEO HemoGenix, Inc.